Prodia Diagnostic Line Tbk vs Singaraja Putra Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Singaraja Putra Tbk. trades at Rp7,000 (market cap 8.51T, 514.5K 24h volume). The key difference: Singaraja Putra Tbk. is far larger — about 18.1× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 514.5K). Which is the better fit depends on your goals.
| PRDL | SINI | |
|---|---|---|
Market Cap | 470.58B | 8.51T |
Volume | 28.43M | 514.5K |
Lot | 284.34K | 5.15K |
Turnover | 7.8B | 3.57B |
Average Price | 274.19 | 6,930.23 |
Value | 7.8B | 3.57B |
Indicative Equilibrium Price | 270 | 7,000 |
Indicative Equilibrium Volume | 2.1K | 469 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Singaraja Putra Tbk (the Company) was established based on Notarial Deed No. 52 dated November 23, 2005 of Notary Sri Herawati Anwar Effendi, S.H. The Company commenced commercialoperations in 2006.
Read more on SINI →